ABSTRACT
Introduction
Human interferon gamma (hIFNγ) is a cytokine secreted in minute amounts by the T lymphocytes upon induction with viruses, bacteria, fungal antigens, immunotoxins, mitogens, etc. It is endowed with multiple biological activities and plays a key role in the modulation of the immune response (21) .
human iFnγ is a 17 kDa single chain protein consisting of 143 amino acids (16) . The active form of hIFNγ is a noncovalent homodimer organised in 6 α-helixes linked by short unstructured regions (6) . It activates the target cells via interaction with the extracellular domain of the hIFNγ receptor complex (5) followed by activation of the receptor associated JAK kinases (12) . The JAK mediated phosphorylation of tyrosine residues at specific receptor sites provides a docking motif for STAT, which is itself also phosphorylated (2, 15) . The activated STAT dissociates from the receptor, dimmerizes and is then translocated to the nucleus through a Ran/importin transport system (17) . The active nuclear import of the protein complex is directed by a short amino acid sequence called nuclear localization sequence (NLS). The NLS generally consists of one or two clusters of basic amino acids separated by a spacer of variable length (8) . Several groups have attempted to locate the elusive NLS in STATs trough mutagenesis of arginine/lysine rich motifs in their molecules (9, 17, 18) . The mutational analyses, however, failed to reveal any conventional NLS in STATs, which is in accordance with a concept that the necessary basic NLS is provided by the STAT ligand. A similar examination of hIFNγ revealed two putative NLS: a downstream, located in the unstructured C-terminus of the protein between amino acid residues 124-132 (20) and an upstream (resembling the nlSs of the SV40 large tumour antigen, polyoma virus and the steroid hormone receptors) identified between the amino acid residues 83-89 (23). Larkin and co-workers (11) found that the upstream NLS is much less efficient than the C-terminal one, which was consistent with the observed loss of more than 90% of biological activity in the protein lacking downstream NLS. The finding that the deletion of the last 23 C-terminal amino acids resulted in inactivation of the hIFNγ was explained by the absence of C-terminal NLS (19) . Nacheva et al., (14) demonstrated that the removal of the entire unstructured (21 amino acid long) C-terminal part from the molecule of hIFNγ led to a 10-fold decrease in its biological activity. It was postulated that the absence of the downstream NLS in hIFNγ can be compensated (at least partly) by its upstream NLS. It was assumed also that the unstructured C-terminal domain in hIFNγ plays modulating but not crucial role for the biological activity of this cytokine. The present study aims to investigate the significance of the putative upstream NLS in hIFNγ for its biological activity. To this end two new variants of the hIFNγ gene are constructed. The first one (Lys/Gln88) contains a Gln substitution for Lys88 in order to disturb the corresponding polybasic NLS and the second one (Lys88/Gln/ΔC) carries both this substitution plus a deletion of the last 21 3'-terminal codons coding for the entire downstream NLS. The two hIFNγ derivative proteins thus obtained were studied for both hIFNγ activities (antiviral and antiproliferative) and for affinity to the hIFNγ receptor.
SIGNIFICANCE OF THE PUTATIVE UPSTREAM POLYBASIC NUCLEAR

Materials and Methods
Chemicals and Bacterial Strains
Restriction endonucleases and other DNA modifying enzymes were purchased from Gibco-BRL (Life Technologies, Inc., Gaithersburg, MD, USA). All other reagents for electrophoresis, DNA manipulations, antiviral and kynurenine assays were products of Merck (Darmstadt, Germany) and Sigma (USA). E.coli LE 392 cells were used for expression of the hIFNγ genes.
DNA Manipulations
The oligonucleotides necessary for modification of the hIFNγ gene were synthesized on a Millipore Cyclon Plus DNA synthesizer (MilliGene, Division of Millipore, Burlington, MA, USA) by the phosphoramidite method and purified by electrophoresis on a polyacrylamide (PAA) urea gel. Their nucleotide sequences are as follows: Forward primer: 5'-CCC AAG CTT ATG CAG GAC C -3' Reverse primer: 5'-GCTT TTC GAA Gtc Atc AcG ttG ct t ttt Gtt G -3'
The forward primer carries a HindIII cloning site (shown in italic) and an ATG codon followed by a nucleotide sequence identical to that of the IFNγ gene.
the reverse primer carries an AsuII cloning site (shown in italic) and introduces a point mutation (in bold) designed to substitute a Gln codon (CAA) for the Lys88 codon AAA. To obtain mutant hIFNγ genes, the genes encoding for the full size (143 amino acids) and the 3'-end truncated (122 amino acids) hIFNγ (14) were amplified by a two step PCR including 5 cycles of annealing at 50 0 C for 1 min and 35 cycles at 60 0 c for 1 min. The PCR products were digested with HindIII and AsuII and cloned in a pBR322-based expression vector (Fig.1) . The primary structure of the derivative hIFNγ genes was verified by DNA sequencing on a DNA Cycle Sequencing machine (Gibco-BRL).
Bacterial Transformation E.coli LE 392 cells were transformed with the expression plasmids by the CaCl 2 method.
PAA-SDS Gel Electrophoresis
PAA-SDS gels (15%) were prepared according to Laemmly (10) and run at 20 mA for 1.5 h. After electrophoresis, the gels were stained by Coomassie blue R250.
Protein Yield Determination
Bacterial cells (6 OD 595 ) from overnight cultures of transformed E.coli LE 392 cells were harvested by centrifugation, resuspended in 1 ml 0.14 M NaCl, 10 mM Tris-HCl, 0.1 mM PMSF and disrupted by sonication. After centrifugation (15 min, 14000g) the supernatants (clear cell lysates) were collected and protein concentration was determined by the Bradford method (4). The lysates were diluted with phosphate-buffered saline (pH 7.2-7.4) to a final protein concentration of 27 μg/ml. Samples of 50 μl were applied on polyvinylchloride 96-well microplates (Costar Ltd., USA) by overnight incubation at 4 0 c and the content of hIFNγ was determined by ELISA with a sequence specific monoclonal antibody.
Bioassays
Clear cell lysates were sterilized by filtration and subjected to serial dilutions suitable for testing of both hIFNγ antiviral and antiproliferative activities. Antiviral activity was determined by the protective effect of the protein on WiSh cells against the cytopathic action of the vesicular stomatitis virus (VSV) (7). Antiproliferative activity was determined by a modified kynurenine bioassay on WISH cells as described earlier (3).
Competition assay
The affinity of the hIFNγ derivative proteins to the cell receptor was analyzed by measuring their capacity to compete with the wild-type hIFNγ protein. Appropriate serial dilutions of cell lysates and purified recombinant hIFNγ (99.5% purity and 5x10
7 IU/ml specific antiviral activity) were prepared. The mutant proteins (in cell lysates) were mixed in equimollar amounts with pure wild-type protein and the antiproliferative activity of the obtained mixtures was determined in a standard kynurenine bioassay. The results were compared with that of the purified wild-type hIFNγ.
Results and Discussion
Design of hIFNγ analogs
It is a routine approach to study the structure-function relationship by mutating the protein molecule by routine recombinant DNA techniques. As mentioned above, to investigate the functional significance of the putative upstream NLS in hIFNγ, two derivative proteins (Lys/Gln88 and Lys88/ Gln/ΔC) were created (Fig. 2) .
The mutations were designed to carry minimum or no effect on the secondary structure of hIFNγ and therefore on its ability to bind the hIFNγ cell receptor. Thus the design of the derivative proteins was based on our model of the electrostatic interactions between the hIFNγ and hIFNγ receptor (1). one of the most general characteristics of a protein in solution is the set of pK values of its titratable (ionizing) groups. Because the electrostatic interactions cannot be experimentally measured, their theoretical prediction is the main tool for their study. In the paper cited above (1) the electrostatic interactions in hiFnγ and the complex hIFNγ-receptor are calculated for two different states of the molecule -alone (in the form of homodimer) and hIFNγ bound to the extracellular domain of the hIFNγ receptor. The study was based on the tree-dimensional structures of hIFNγ (6, 22) and clearly demonstrated that a number of titratable groups (mainly basic) had a remarkable shifts in their pK values after binding to the hIFNγ receptor. It is worth mentioning that the groups having high desolvation energy in both states (free and in a complex with the receptor) usually corresponded to the highly conserved amino acids. Four of them, Tyr53, Lys61, Lys88, and Glu112 are conserved in all IFNγ sequences (6, 13) , which is an indication for their functional significance.
calculating the ionisation of titratable groups in the area of the putative upstream NLS for the two (free and bound to the receptor) states of hIFNγ we found that most of the basic groups were drastically desolvated. Our results showed that both the protonation and solvent accessibility of Lys86 and Lys87 in the putative upstream NLS differed significantly in the two subunits (monomers) of the homodimer and also that the Lys88 was inaccessible to the solvent in both subunits. In the hIFNγ/receptor complex Lys86 and Lys87 had high solvent accessibility in both subunits, while Lys88 was still inaccessible ( Table 1 ). These data indicated that the Lys88 was located at a distance from the receptor binding site and therefore its mutation would not affect the affinity of the protein to the receptor. In order to minimize the changes in protein solubility related to the changes in local polarity we chose to substitute Gln88 for Lys88 (Fig. 2) . Furthermore, to evaluate the potential compensatory effect of the downstream NLS on the function of the upstream NLS, we constructed a second mutant in which the last 21 C-terminal amino acids (carrying the entire downstream NLS) were deleted (Fig.2) . The mutated hIFNγ genes were prepared and expressed in E. coli LE392 as described in Materials and Methods. The expression of the resulted proteins (Fig. 3) is presented in Fig. 4 .
Biological activity of the hIFNγ analogs
In order to avoid artifacts related to the incorrect folding of the purified recombinant proteins, biological activity of the hIFNγ derivatives was measured directly in clear cell lysates. Thus the insoluble fraction (inclusion bodies) was removed and the activity of the proteins was determined using the soluble (cytosolic fraction) only. Two biological activities, antiviral and antiproliferative (typical for the hIFNγ) were measured. The first one was determined by the protective effect of hIFNγ on WISH cells against the cytopathic action of the VSV and the second one was measured by the "kynurenine bioassay" using the same cell line. To determine specific activity of the tested proteins, their content in the clear cell lysates was measured by ELISA using anti-hIFNγ monoclonal antibodies and pure recombinant hiFnγ as a standard. 
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As seen in Table 2 , the single amino acid substitution in the construct Lys/Gln88 resulted in a 1000-fold decrease in the hiFnγ activity, whereas the activity of the truncated construct (Lys88/Gln/ΔC) was 10-fold lower than that of the Lys/Gln88 mutant. The affinity of the new hIFNγ constructs to the hIFNγ receptor was estimated by measuring their capacity to compete with the wild-type hIFNγ for its cellular receptor. These experiments were performed as described in Material and Methods using WISH cells (known to be enriched in hIFNγ receptors). The results presented in Table 2 indicate that the coincubation of the mutant Lys/Gln88 with the wild-type hIFNγ led to a 30% decrease in its antiproliferative activity. We assume that inhibition higher than 30% could not be achieved because of the residual biological activity of the hIFNγ mutant (see Table 2 ). The mutant hIFNγ with fully truncated C-terminus (Lys88/Gln/ΔC) demonstrated approximately 50 % inhibition of the hIFNγ activity thus confirming our previous data showing that truncation of C-terminal aminoacids stabilizes the hiFnγ/receptor complex (1). These data indicate that the mutant proteins are capable of interacting with the hIFNγ receptor and are inefficient in triggering the intracellular signal transduction pathway.
Conclusions
The role of the putative upstream NLS of hIFNγ was investigated by site directed mutagenesis at the area of both upstream and downstream NLSs. Two derivative proteins were thus obtained containing either a Gln88 for Lys88 substitution (Lys88/Gln) or Gln88 for Lys88 substitution combined with a 21 aminoacid C-terminal deletion (Lys88/Gln/ΔC). The first construct demonstrated a 1000-fold lower biological activity in comparison with the wild-type hIFNγ and the second one was 10-times less active than the Lys88/Gln mutant. In a competition bioassay both constructs behaved as efficient competitors of the wild-type hIFNγ for the cellular receptor. the latter means that the putative upstream nlS is crucial for the biological activity of hIFNγ but it is dispensable for the interaction of the protein with the cellular receptor. Based on these data we are tempted to speculate that the upstream NLS has great functional importance for the signal transduction as compared to the downstream NLS.
